Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Innocan Pharma Corp (INNPF)

Innocan Pharma Corp (INNPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Innocan Pharma Secures Patent for LPT-CBD in Japan, Strengthening Global IP Portfolio Tipranks - Thu Oct 16, 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. InnoCan Pharma...

INNPF : 6.2500 (+5.93%)
Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection PR Newswire - Thu Sep 18, 2025

HERZLIYA, Israel and CALGARY, AB , Sept. 18, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in...

INNO : 17.72 (+0.57%)
INNPF : 6.2500 (+5.93%)
Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection Newswire.ca - Thu Sep 18, 2025

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 8.0800 (-1.22%)
INNPF : 6.2500 (+5.93%)
Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference Newswire.ca - Mon Sep 15, 2025

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 8.0800 (-1.22%)
INNPF : 6.2500 (+5.93%)
Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference PR Newswire - Mon Sep 15, 2025

HERZLIYA, Israel and CALGARY, Alberta , Sept. 15, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer...

INNO : 17.72 (+0.57%)
INNPF : 6.2500 (+5.93%)
Innocan Pharma Announces Details of Proposed Share Consolidation PR Newswire - Fri Aug 29, 2025

HERZLIYA, Israel and CALGARY, Alberta , Aug. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (" Innocan " or the " Company ") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

INNO : 17.72 (+0.57%)
INNPF : 6.2500 (+5.93%)
Innocan Pharma Announces Details of Proposed Share Consolidation Newswire.ca - Fri Aug 29, 2025

/CNW/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that further to its press release...

INNO.CN : 8.0800 (-1.22%)
INNPF : 6.2500 (+5.93%)
Innocan Pharma Announces First Half Of 2025 Financial Results Newswire.ca - Wed Aug 27, 2025

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on...

INNO.CN : 8.0800 (-1.22%)
INNPF : 6.2500 (+5.93%)
Innocan Pharma Announces First Half Of 2025 Financial Results PR Newswire - Wed Aug 27, 2025

HERZLIYA, Israel and CALGARY, AB , Aug. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the " Company " or " Innocan "), a...

INNO : 17.72 (+0.57%)
INNPF : 6.2500 (+5.93%)
Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada Newswire.ca - Fri Aug 22, 2025

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 8.0800 (-1.22%)
INNPF : 6.2500 (+5.93%)

Barchart Exclusives

Is This Dividend Stock a Buy Now After Falling Over 11% from Its 2026 Highs? Barchart - Wed Feb 18, 6:30PM CST
Citigroup shares are down 11% from their 2026 highs. The stock has a healthy dividend yield of 2.1% and looks like a good buy after the correction. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot